Question 1

What is the catalog number for Human VEZF1 Knockout A549 cell line?

Accepted Answer

The catalog number for Human VEZF1 Knockout A549 cell line is A549KO-20130.

Question 2

What sizes are available for Human VEZF1 Knockout A549 cell line?

Accepted Answer

Human VEZF1 Knockout A549 cell line is available in the following size(s): 1 Vial.

Question 3

Is Human VEZF1 Knockout A549 cell line in stock?

Accepted Answer

Human VEZF1 Knockout A549 cell line is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Human VEZF1 Knockout A549 cell line used for?

Accepted Answer

Engineered clonal A549 cells with VEZF1 gene knockout, sequence confirmed.

Question 5

Do you provide a Certificate of Analysis (CoA) for this product?

Accepted Answer

A Certificate of Analysis is available for most products upon request. Contact our support team with the lot number to obtain the relevant CoA.

Question 6

Is this product suitable for live cell imaging?

Accepted Answer

Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.

Question 7

Is this product covered by a money-back guarantee?

Accepted Answer

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.

Human VEZF1 Knockout A549 cell line

Product Specifications

Frequently Asked Questions

Explore Other Products

MYBBP1A Recombinant Rabbit Monoclonal Antibody [JB40-09]

Melanoma Marker (HMB45 + A103 + T311), CF488A conjugate, 0.1mg/mL

2-(Phenyl-d5)-2-propanol

Anti-TIM10| Mitochondrial import inner membrane translocase subunit TIM10

MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (MUC1/2278R), CF740 conjugate, 0.1mg/mL

VWA3A Human Gene Knockout Kit (CRISPR)